|
PUT
|
$0
|
100
|
Q3 2024
Reduced 99.93%
|
|
|
CALL
|
$0
|
8.7K
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
5.8K
|
Q3 2024
New holding
|
|
Smith & Wesson Brands Inc
|
CALL
|
$0
|
77.9K
|
Q3 2024
Reduced 11.98%
|
|
Smith & Wesson Brands Inc
|
PUT
|
$0
|
31.5K
|
Q3 2024
Added 452.63%
|
|
|
CALL
|
$0
|
700
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
2.1K
|
Q3 2024
New holding
|
|
Stanley Black & Decker Inc
|
CALL
|
$0
|
35.3K
|
Q3 2024
Reduced 62.33%
|
|
Stanley Black & Decker Inc
|
PUT
|
$0
|
131K
|
Q3 2024
Added 29.52%
|
|
|
CALL
|
$0
|
178K
|
Q3 2024
Added 70.08%
|
|
|
PUT
|
$0
|
137K
|
Q3 2024
Reduced 27.73%
|
|
|
CALL
|
$0
|
529K
|
Q3 2024
Reduced 15.69%
|
|
|
PUT
|
$0
|
27K
|
Q3 2024
Reduced 5.59%
|
|
Springworks Therapeutics Inc
|
CALL
|
$0
|
7.1K
|
Q3 2024
Added 222.73%
|
|
Springworks Therapeutics Inc
|
PUT
|
$0
|
19.2K
|
Q2 2024
Added 3740.0%
|
|
|
CALL
|
$0
|
6.5K
|
Q3 2024
Reduced 75.38%
|
|
|
PUT
|
$0
|
1.8K
|
Q3 2024
Added 38.46%
|
|
|
CALL
|
$0
|
400
|
Q3 2024
Reduced 71.43%
|
|
|
CALL
|
$0
|
203K
|
Q3 2024
Reduced 61.35%
|
|
|
PUT
|
$0
|
256K
|
Q3 2024
Added 50.26%
|
|
|
CALL
|
$0
|
111K
|
Q3 2024
Added 17.82%
|
|
|
PUT
|
$0
|
50.4K
|
Q3 2024
Reduced 12.04%
|
|
|
CALL
|
$0
|
700
|
Q3 2024
Added 16.67%
|
|
|
PUT
|
$0
|
1K
|
Q3 2024
Reduced 54.55%
|
|
|
CALL
|
$0
|
209K
|
Q3 2024
Added 62.49%
|
|
|
PUT
|
$0
|
226K
|
Q3 2024
Added 178.79%
|
|
|
CALL
|
$0
|
200
|
Q3 2024
Reduced 90.48%
|
|
|
PUT
|
$0
|
2K
|
Q3 2024
Reduced 78.95%
|
|
Syros Pharmaceuticals Inc
|
CALL
|
$0
|
5K
|
Q3 2024
Reduced 13.79%
|
|
|
CALL
|
$0
|
259K
|
Q3 2024
Added 15.44%
|
|
|
PUT
|
$0
|
17.7K
|
Q3 2024
Reduced 79.25%
|
|
|
CALL
|
$0
|
3.8M
|
Q3 2024
Reduced 17.62%
|
|
|
PUT
|
$0
|
1.36M
|
Q3 2024
Reduced 30.04%
|
|
|
CALL
|
$0
|
5.3K
|
Q3 2024
Reduced 38.37%
|
|
|
PUT
|
$0
|
7.9K
|
Q3 2024
New holding
|
|
Transact Technologies Inc
|
PUT
|
$0
|
300
|
Q2 2024
New holding
|
|
Takeda Pharmaceutical CO LTD
|
CALL
|
$0
|
5.2K
|
Q3 2024
Added 100.0%
|
|
Takeda Pharmaceutical CO LTD
|
PUT
|
$0
|
300
|
Q3 2024
Added 50.0%
|
|
|
CALL
|
$0
|
174K
|
Q3 2024
Reduced 39.1%
|
|
|
PUT
|
$0
|
314K
|
Q3 2024
Added 37.61%
|
|
|
CALL
|
$0
|
29.1K
|
Q3 2024
Reduced 18.26%
|
|
|
PUT
|
$0
|
100
|
Q1 2024
Reduced 87.5%
|
|
|
CALL
|
$0
|
13.9K
|
Q3 2024
Reduced 75.22%
|
|
|
PUT
|
$0
|
253K
|
Q3 2024
Added 0.52%
|
|
|
CALL
|
$0
|
158K
|
Q3 2024
Reduced 14.15%
|
|
|
PUT
|
$0
|
42.8K
|
Q3 2024
Added 48.61%
|
|
|
PUT
|
$0
|
100
|
Q2 2024
Reduced 95.0%
|
|
Tarsus Pharmaceuticals Inc
|
CALL
|
$0
|
24.7K
|
Q3 2024
Added 76.43%
|
|
|
CALL
|
$0
|
200
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
1.7K
|
Q3 2024
Added 750.0%
|
|